The CMS Global Lifesciences Forum 2015 brought together senior executives involved in Lifesciences from around Europe as well as other experts to discuss the issues driving the industry. The forum explored M&A, liability risks, marketing and distribution, eHealth and mHealth, big data, nutraceuticals and the protection of trade secrets.
- There are major M&A opportunities in the lifesciences industry, particularly in the fragmented medical device sector
- eHealth and mHealth devices and apps are changing the way patients interact with their doctors and medicine
- Big data has great potential to help the medical industry, but must overcome data protection risks before being fully utilised
- Changes to the way trade secrets are defined and regulated across the EU could have implications for clinical trials
Read more in the attached press release.